CINFA BIOTECH
Cinfa Biotech was created in 2013 as part of the Spanish Cinfa Group. The company conduct biosimilars development and manufacturing exclusively in Europe. Highest European quality standards based on strict guidelines and their specialist know-how are the key to their success in the global biosimilars market. They currently have two product candidates in development including: Cinfa Biotech’s lead product candidate, pegfilgrastim, a biosimilar version of Neulasta® (INN: pegfilgrastim) to treat chemotherapy-induced neutropenia. Pegfilgrastim, a granulocyte colony-stimulating factor (G-CSF) receptor agonist, is used to stimulate bone marrow to produce more neutrophils in order to decrease the incidence of infection in patients undergoing chemotherapy.
CINFA BIOTECH
Industry:
Biopharma Biotechnology Manufacturing
Founded:
2013-01-01
Address:
Pamplona, Navarra, Spain
Country:
Spain
Website Url:
http://www.cinfabiotech.com
Status:
Active
Contact:
+34 948 33 50 05
Email Addresses:
[email protected]
Technology used in webpage:
Microsoft Azure DNS
Similar Organizations
Allergan Biologics
Allergan Biologics involves in development and clinical manufacturing facility and is a Centre of Excellence for Biologics development.
Centaur Biopharmaceutical Services
Centaur Biopharmaceutical Services is a contract development and manufacturing organization.
Rottendorf Pharma
Rottendorf Pharma is a first-class contract development and manufacturing organization.
Official Site Inspections
http://www.cinfabiotech.com Semrush global rank: 10.55 M Semrush visits lastest month: 266
Unable to get host informations!!!
More informations about "Cinfa Biotech"
Cinfa Biotech GmbH - life-sciences-europe.com
Oct 2, 2014 Cinfa Biotech is headquartered in Pamplona, Spain, with offices in Munich, Germany. The company was founded in 2013 and received an initial investment of EUR 70 …See details»
Cinfa Biotech - 2025 Company Profile - Tracxn
Cinfa Biotech - Spanish clinical-stage biosimilar development company. Raised a total funding of $93M over 1 round from 1 investor.See details»
Cinfa Biotech S.L. - Ownership and Business Overview | Mergr
Oct 10, 2018 Who owns Cinfa Biotech S.L.? Cinfa Biotech S.L. is owned by Mundipharma International. It was acquired on October 10, 2018.See details»
Cinfa Biotech - Products, Competitors, Financials, Employees ...
Cinfa Biotech Unclaimed cinfabiotech.com Overview & Products Financials People Founded Year 2013 Stage Acquired | AcquiredSee details»
Cinfa Biotech 2025 Company Profile: Valuation, …
Information on acquisition, funding, investors, and executives for Cinfa Biotech. Use the PitchBook Platform to explore the full profile.See details»
Cinfa Group | Cinfa Internacional
Cinfa is part of Infarco, a parent company for several firms that handle different business lines in the world of health, and which have gradually been formed to make what is now Cinfa …See details»
Cinfa Biotech SL:Company Profile & Technical …
Discovery Company profile page for Cinfa Biotech SL including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Cinfa Biotech - Owler
Cinfa Biotech’s Profile, Revenue and Employees. Cinfa Biotech develops and commercializes biosimilars for the treatment of cancer and inflammatory diseases. Cinfa Biotech’s primary …See details»
Cinfa Biotech Overview | SignalHire Company Profile
Cinfa Biotech is a private company that has been in the industry for 9 years. The company currently specializes in the Management Consulting, Pharmaceuticals areas. The position of …See details»
Cinfa Biotech SL: Drug pipelines, Patents, Clinical trials - Synapse
Explore Cinfa Biotech SL with its drug pipeline, therapeutic area, technology platform, 2 clinical trials.See details»
CINFA BIOTECH - VentureRadar
Evive Biotech China n/a Evive Biotech is a global biologics company focused on oncology, inflammatory and metabolic diseases. As the first biopharmaceutical company to build a …See details»
Cinfa Biotech CEO, Founder, Key Executive Team, Board of …
Explore {Cinfa Biotech's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Mundipharma buys Spanish biosimilars firm Cinfa Biotech
Oct 10, 2018 Mundipharma, a network of independent pharma companies, has bought Spanish biosimilars development company Cinfa Biotech. The deal will see Mundipharma, which …See details»
Cinfa Internacional
Cinfa Group has 55 years' experience, and a team of more than 2,200 professionals committed to offer top quality products that range from prescription and non-prescription medications, to …See details»
Biotech | Cinfa Internacional
This Cinfa website uses own and third-party cookies and technologies, to obtain information about your preferences, browsing and behaviour on this website. This allows us to provide you …See details»
Cinfa Biotech SL - Drug pipelines, Patents, Clinical trials - Synapse
Dec 1, 2024 Explore Cinfa Biotech SL with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, Drug:Pegfilgrastim biosimilar (Cinfa Biotech SL).See details»
Cinfa Biotech SL: 药物管线，专利，临床试验 - 智慧芽新药情报库
了解Cinfa Biotech SL (Cinfa Biotech SL)公司的药物管线，治疗领域，技术平台，以及它的2项临床试验，药物:培非格司亭生物类似药（Cinfa Biotech SL）。See details»
CINFA BIOTECH - VentureRadar
Y Biologics South Korea Private Founded in 2007, Y-Biologics is a biotech company focusing on the discovery and development of novel antibody therapeutics based on its human antibody …See details»
Vision 2028: How China could impact the global biopharma industry
Acturing organizations (CDMOs) are an important part of Chi —received more than three-quarters of their revenues from non-Chin Some CROs and CDMOs are also expanding their …See details»
Trump tariffs drive pharma manufacture to US but risk inflation …
2 days ago Trump tariffs drive pharma manufacturing to US but risk inflation and disruption Pressure may grow on companies to repatriate production, raising production costs and …See details»